Abstract:OBJECTIVE:Recent reports have suggested that long non-coding RNA LBX2 antisense RNA 1 (LBX2-AS1) acts as an important regulator in cancer progression. This study aimed to investigate the clinical significance of LBX2-AS1 in non-small cell lung cancer (NSCLC) patients and its biological functions.PATIENTS AND METHODS:The expressions of LBX2-AS1 were examined in 165 paired NSCLC tissues and adjacent normal tissues from NSCLC patients by qRT-PCR. The clinical significance of LBX2-AS1 was determined using a series of statistical methods. The effects of LBX2-AS1 knockdown on NSCLC cell proliferation, migration, and invasion were investigated by CCK-8 assays, colony formation assays, EdU proliferation assays, Wound healing assays, and transwell assays. The promotive roles of LBX2-AS1 on Notch1 signal were determined using RT-PCR and Western blot.RESULTS:We found that LBX2-AS1 was highly expressed in NSCLC tissues and cell lines. The increased levels of LBX2-AS1 were observed to be positively correlated with TNM stage, histological grade, and lymph node metastasis. Furthermore, the Kaplan-Meier survival curves indicated that patients with higher expressions of LBX2-AS1 had unfavorable overall survival. Lost-of-functions assays revealed that the knockdown of LBX2-AS1 in H1299 and A549 cells inhibited cell proliferation, migration, and invasion. Mechanistic studies revealed that the suppression of LBX2-AS1 resulted in the reduced expressions of Notch1, p21, and Hes1, suggesting that LBX2-AS1 might promote the activation of the Notch pathway.CONCLUSIONS:Our study identified a novel NSCLC-related lncRNA LBX2-AS1, which may represent a novel prognostic biomarker and a potential therapeutic target for NSCLC.

The role of LncRNA LBX2-AS1 in cancers: functions, mechanisms and potential clinical utility

The oncogenic potentials and diagnostic significance of long non-coding RNA LINC00310 in breast cancer.

Promising Long Noncoding RNA DLX6-AS1 in Malignant Tumors

LncRNA PCGEM1 in Human Cancers: Functions, Mechanisms and Promising Clinical Utility

Oncogenic Roles and Mechanisms of Lncrna AGAP2-AS1 in Human Solid Tumors.

Novel Long Non-Coding RNA LBX2-AS1 Indicates Poor Prognosis and Promotes Cell Proliferation and Metastasis Through Notch Signaling in Non-Small Cell Lung Cancer.

DLX6-AS1: An Indispensable Cancer-related Long Non-coding RNA

A Promising New Cancer Marker: Long Noncoding RNA EGFR-AS1

Biological functions and clinical significance of long noncoding RNAs in bladder cancer

Biological roles of SLC16A1-AS1 lncRNA and its clinical impacts in tumors

Role of Cytoplasmic Lncrnas in Regulating Cancer Signaling Pathways

Current Research Progress of the Role of LncRNA LEF1-AS1 in a Variety of Tumors.

New Insights into LINC00346 and its Role in Disease

Emerging Roles of a Pivotal Lncrna SBF2-AS1 in Cancers

DLX6-AS1 is a potential biomarker and therapeutic target in cancer initiation and progression

The tale of SOX2: Focusing on lncRNA regulation in cancer progression and therapy

LncRNA LBX2-AS1 Promotes Proliferation and Migratory Capacity of Clear Cell Renal Cell Carcinoma Through Mitophagy

Biological Functions and Molecular Mechanisms of LINC01116 in Cancer

Long non-coding RNA LBX2-AS1 predicts poor survival of colon cancer patients and promotes its progression via regulating miR-627-5p/RAC1/PI3K/AKT pathway

LncRNA SBF2-AS1: A Budding Star in Various Cancers

Oncogenic Roles of the Lncrna LINC00460 in Human Cancers